Co- Founder And Executive Vp Business Development (Retired)
Co-Founder of Ambiopharm, headquartered at our cGMP peptide manufacturing facility in North Augusta, South Carolina USA. AmbioPharm possesses the widest range of skill sets for solid and solution-phase chemistry of any peptide manufacturer, and our USA and Chinese facilities are capable of handling any manufacturing scale. We focus on clinical and commercial scale production of peptides and filing DMFs, and we design protocols for producing bulk peptide to any specification at increasing scales. In our cGMP facility in Shanghai, China, we manufacture peptide APIs at very large scales, and provide pilot manufacturing, process development, raw materials, building blocks, custom and generic peptides. In addition to manufacturing peptides as API’s we also perform conjugations to proteins, toxoids, antifungals, KLH, and PEG. Our clients purchase cGMP manufacturing services from AmbioPharm because of price, flexibility, and communication.